Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors
✍ Scribed by Ruggiero, Antonio; Rizzo, Daniela; Attinà , Giorgio; Lazzareschi, Ilaria; Maurizi, Palma; Ridola, Vita; Mastrangelo, Stefano; Migliorati, Roberta; Bertolini, Patrizia; Colosimo, Cesare; Riccardi, Riccardo
- Book ID
- 121384619
- Publisher
- Springer US
- Year
- 2013
- Tongue
- English
- Weight
- 170 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Although temozolomide is active against recurrent malignant glioma, responses in many patients are modest and short‐lived. Temozolomide may prove more effective in combination with other agents. Therefore, combination oral chemotherapy for these patients is a particularly
Pre-clinical data and adult experience suggests that topoisomerase targeted anti-cancer agents may be highly schedule dependent, and efficacy may improve with prolonged exposure. To investigate this hypothesis, 28 children with recurrent brain and solid tumors were enrolled in a phase II study of or